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Histologically diagnosed cancers in South Africa, 1988
F. SITAS
Abstract The National Cancer Registry (NCR) collects
infonnation on cancer diagnoses via a nation-wide
network of public and private pathology labora-
tories. In 1988, 45 570 new laboratory-diagnosed
cancer cases were reported to the NCR. Minimal
age-standardised registration rates for black,
white, coloured and Asian males were 112,2, 229,9,
192,2 and 91,6/100 000, respectively, and those for
females 107,2,201,3 148,1 and 118,0. About 40% of
cancers in females and 31,3% in males occurred in
potentially economically active adults aged 15 - 54
years. The top five cancers in males were: (z) basal
cell skin cancer; (iz) cancer of the prostate gland;
(iiz) cancer of the oesophagus; (iv) lung cancer;
and (v) squamous cell skin cancer. In females they
were: (z) cancer of the cervix; (iz) breast cancer;
(iiz) basal cell skin cancer; (iv) squamous cell skin
cancer; and (v) cancer of the oesophagus. Despite
under-reporting, a nwnber of cancers, especially
those of the oesophagus and cervix in blacks and
skin cancers in whites, rank among the highest in
the world. Moreover, 40,4% of the cancers in adult
males (15 - 64 years) and 15,2% of those in adult
females were associated with tobacco use. It is rec-
ommended that: (z) regional cancer registries be
set up in a number of regions to provide informa-
tion on the true burden of cancer and to monitor
interventions; (ii) a national screening pro-
gramme for cancer of the cervix be established;
(iiz) detailed studies on lifestyle and dietary caus-
es, especially of cancers related to tobacco con-
sumption and cancers of the oesophagus, cervix
and skin, be undertaken; and (iv) the impact of
mv on virus-related cancers be monitored.
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I n order to assist in the planning and evaluation ofcancer control programmes, the National CancerRegistry (NCR) was established in 1986 to record
the incidence of histologically diagnosed cancer in South




Methods of data collection and coding of cancers are
described elsewhere. I,' Briefly, the NCR collects infor-
mation on incident cases of cancer from a network of
most (85) private and public histopathology and haema-
tology laboratories throughout South Africa (including
Transkei, Ciskei, Bophuthatswana and Venda (TBVC).
From 1988 onwards, data from cytology laboratories
were also included_
Population
Population denominator data were obtained from extra-
polations of the 1985 census to 1988 by the Central
Statistical Services. Estimates of the total population of
the TBVC homelands for 1988 were obtained from the
Epidemiology Directorate of the Deparnnent of Health
and Population Development (R. Swanenvelder) and
added to the South African population data, in propor-
tion to the age structure of the South African population
data.
Cancer registration rates
Age- and sex-specific frequencies of cancer are shown in
Tables I and n. Age-standardised registration rates
(ASR) were calculated using the direct method of stan-
dardisation and the 'world standard population'.
Cumulative lifetime risks (LR) of developing cancer
were calculated using standard procedures.' Calcula-
tions of crude rates, ASR and LR exclude basal and
TABLEt
Frequency of histologically diagnosed cancer by age group, 1988
Age group (yrs)
Unknown 0-14 15 - 24 25 - 34 35 - 44 45 - 54 55 - 64 ;;. 65 Total
Asian 44 30 45 41 108 164 179 138 749
Female 17 14 27 27 88 94 106 74 447
Male 18 16 17 13 20 67 72 62 285
Unknown 9 0 1 1 0 3 1 2 17
Black 1785 477 722 1 118 2193 3175 3918 4047 17435
Female 841 214 360 699 1287 1554 1753 1793 8501
Male 825 250 355 417 896 1604 2137 2238 8722
Unknown 119 13 7 2 10 17 28 16 212
Coloured 184 101 148 209 458 717 856 922 3595
Female 91 50 75 142 308 380 340 419 1805
Male 92 50 73 67 150 337 516 502 1787
Unknown 1 1 0 0 0 0 0 1 3
White 2891 223 692 764 2054 2919 4361 8725 22629
Female 1 081 98 259 431 1096 1 416 1860 3865 10106
Male 1556 123 425 331 946 1476 2461 4816 12134
Unknown 254 2 8 2 12 27 40 44 389
All 5193 846 1668 2167 4906 7122 9515 14153 45570
Female 2092 384 741 1 317 2830 3515 4136 6279 21294
Male 2556 442 897 844 2050 3557 5299 7800 23445
Unknown 545 20 30 6 26 50 80 74 831
Population unknown - 1 162.
squamous cell skin cancers. LR and ASR are also TABLE 11.
adjusted for the proportion of people in the 'age Top 10 histologically diagnosed cancers, by sex, 1988
unknown' category for each site. Frequencies, crude Site No. % Crude' ASRt . Riskl
rates, ASR and LR for the top 10 cancers were cal-
culated for each sex (Table m, and for each population Females
group and sex (Table III). Cancers are ranked according Cervix 3507 16,47 19,65 28,29 31,66
to their ASR. Breast 3324 15,61 18,62 27,60 31,95
BCC 2475 11,62 13,87 20,32 44,17
Cancers associated with various causes SCC 1006 4,72 5,64 8,43 99,51Oesophagus 844 3,96 4,73 7,38 110,39
Over 80% of cancers are caused by external (non- Uterus 850 3,99 4,76 7,34 109,20
inherited) factors" An anempt was therefore made to Colon 666 3,13 3,73 5,65 147,56
apportion the cancer panern in South Africa to a num- Lung 622 2,92 3,48 5,56 139,39
ber of factors relevant to South African conditions. Ovary 584 2,74 3,27 4,79 185,69
Inhalation of tobacco smoke or tobacco chewing, for Non-Hodg.
example, is associated with cancers of the oral cavity, lymphoma 519 2,44 2,91 4,19 208,83
larynx, nasopharynx, lung, oesophagus, pancreas, blad- Other 5693 26,74
der, kidney and stomach.' Cancer of the nasopharynx, --
cervix, liver, stomach and anogenital region, Kaposi's Total 21294 100,00 99,79 145,95 6,8
sarcoma, non-Hodgkin's lymphoma and some leukae-
Malesmias are associated with infection by viruses and bac-
teria. Of concern is whether the rate of any of these BCC 3865 16,49 21,72 36,37 24,37
cancers will increase because the HIV epidemic is Prostate 1800 7,68 10,11 19,11 43,79
increasing the numbers of irnmunosuppressed indivi- Oesophagus 1973 8,42 11,09 18,15 44,75
duals. 6 Cancers of the female breast and those of the Lung 1844 7,87 10,36 17,38 44,55
oesophagus, stomach, intestine, colon, rectum, prostate, SCC 1708 7,29 9,60 16,52 53,41
ovary and endometrium are more common in societies Bladder 1040 4,44 5,84 10,35 78,02
with a high consumption of saturated fats and/or low Stomach 798 3,40 4,48 7,43 114,14
consumption of fruits and vegetables. 7 Basal cell and Liver 727 3,10 4,08 6,23 127,08
squamous cell cancers and melanomas are associated Non-Hodg.
with exposure to solar ultraviolet radiation. 8 lymphoma 708 3,02 3,98 6,00 143,36
Colon 611 2,61 3,43 5,91 147,56
Other 8291 35,36--
Results Total 23445 100,00 100,42 163,23 6,8
Sex unknown 831
Contributing centres Total cancer
About 85 public and private histology, haematology and
cases 45570
cytology laboratories throughout South Africa, the '. t: per 100 000.
TBVC states and other regions reported 45 570 new
l: risk is expressed as 1 in X number of people.
t. l: adjusted for age unknown.
cancer cases to the NCR, of which 96,1 % had complete BCC = basal cell carcinoma; SCC = squamous cell carcinoma.
information on sex and population group (Table 1). South African population: females - 17 850 422; males - 17 797 905.
Age and sex distribution
A toral of21 294 new female and 23 445 new male can-
cer.cases were ~ecorded in 1988; in 831 (1,8%) the sex
was unknown, and 5 193 (11,3%) had no information
on age." The age-specific frequency of all cancers for
males and females is shown in Table 1. It is noteworthy
that 39,5% of cancers in females and 31,3% in males
occurred in potentially economically active adults aged
15 - 54 years. Cancers in children (0 - 14 years) com-
prised less than 2% of all cancers.
South African population
The total South African population (including TBVC)
was estimated at 35 648 327 persons, 17· 850 422
females and 17797905 males (Tables Il and Ill).
Histologically diagnosed cancer
registration
Histologically diagnosed cancer registration data for the
top 10 cancer sites are shown in Tables Il and Ill. The
ASR for females was 145,95/100000 and that for males
163,23. LR for both sexes were similar, 1/7. ASRs for
black, white, coloured and Asian males were 112,2,
229,9, 192,2 and 91,6/100 000, respectively, and those
for females 107,2,201,3, 148,1 and 118,0. The mini-
mal LR of developing cancer (excluding basal and squa-
mous cell cancers) was at least 1/7,5 for black males and
at least 1/8 for black females. Of white males and white
females at least 1/4,3 and liS, respectively, developed
cancer. Among coloureds the LR was at least liS for
males and at least 1/6,6 for females, and among Asians
it was 1/9,6 for males and 1/8,4 for females.
Ranking of cancers
Age-specific frequency and incidence. tabulations of his-
tologically diagnosed cancer are presented elsewhere.'
Crude and ASR per 100 000 for the top 10 cancer
sites, the percent contribution and the LR of develop-
ing each cancer are summarised in Tables Il and Ill.
Cancers are ranked according to their ASR, so in some
cases there is a discrepancy between the relative
frequency of a cancer and its ASR ranking. In females,
the top 10 cancers were: (z) cervix (16,47%); (iz) breast
(15,61 %); (iiz) basal cell skin cancer (11,62%); (iv)
squamous cell skin cancer (4,72%); (v) oesophagus
(3,96%); (vz) uterus (corpus uteri) (3,99%); (viz) colon
(3,13%); (viiz) lung (2,92%); (ix) ovary (2,74%); and
(x) non-Hodgkin's lymphoma (2,44%). In males, the
top 10 cancers were: (i) basal cell skin cancer
(16,49%); (iz) prostate (7,68%); (iiz) oesophagus
(8,42%); (iv) lung (7,87%); (v) squamous cell skin
cancer (7,29%); (vz) bladder (4,44%); (viz) stomach
(3,4%); (viiz) liver (3,1 %); (ix) non-Hodgkin's lym-
phoma (3,02%); and (x) colon (2,61 %).
The top 10 cancer sites by population group and sex
are set Out in Table m. Cancer of the cervix was the
commonest cancer in black and coloured females (ASR
39,28 and 31,031100 000, respectively), the 3rd most
common in Asians (ASR 11,49) and the 9th most com-
mon in whites (ASR 8,86). Cancer of the cervix com-
prises· 2,65% of all cancers in white females and 32,74%
in black females. Overall, cancer of the cervix comprises
16;47% of all female cancers. One in 21,25 black
females will develop cancer of the cervix in their lifetime
(0 - 74 years) if current patterns persist. In contrast,
11108,03 white females will develop cancer of the cernx
in their lifetime, corresponding to a relative registration
rate (age-adjusted 0- 74 years) between black and white
of5,1.
Causes of cancer (15 - 64 years)
In the age group 15 - 64 years, 5 166 cancers in males
and 1 958 in females were associated with tobacco use
(see 'Methods' for list), comprising 40,9% of cancers in
adult males and 15,6% of those in females. A total of
3 922 women (31,3%) and 2 204 men (17,4%) aged
15 - 64 years developed cancers associated with infec-
tious agents. A total of 4640 cancers in women (37,0%)
and 3 274 in men (25,9%) were associated with other
dietary, reproductive and lifestyle factors. Exposure to
solar radiation was associated with 1 738 (skin) cancers
in women (13,9%) and 2 833 (22,7%) in men, albeit
that 84,8% of skin cancers in females and 91,6% of
those in males are basal and squamous cell carcinomas,
which are rarely fatal.
Discussion
Almost all private laboratories and all public pathology
laboratories send data to the NCR. The majority of all
laboratory-diagnosed cancers are therefore recorded.
The total of 45 570 cases recorded in 1988 is higher
than the number of cancers recorded in previous years.
In 1986, 34 -590 and in 1987, 34 393 cancer cases were
recorded. The increase of 24,5% between 1987 and
1988 is attributed to cytology laboratories sending their
data from 1988 onwards and to a more efficient repon-
ing system among all laboratories. Comparisons of rates
between calendar years would therefore be misleading.
The 1987 total of 34 393 is lower than the 38 027 cases
previously recorded.2 This is because a more sensitive
method has since been applied to search for duplicate
entries. This led to the exclusion of 3 634 cases from the
1987 data.
Cancer would bring most people to the attention of a
medical doctor." However, if entry to a register were to
be restricted to laboratory-confirmed cases alone, varia-
tions in registration would in pan reflect access to diag-
nostic facilities rather than the underlying morbidity
(incidence) rate. In The Gambia, for example, 30% of
cancers are histologically verified,1O and in Mali, 50%. tl
In the UK histological verification varies; for example,
the figure for males in Trent is 45% and that in east
Scotland 97%.12 In a pilot population-based cancer
registry established in a South African black rural area,
42% of all cancers were diagnosed without laboratory
verification (unpublished data). In a study of cancer of
the oesophagus in Transkei, 48% of all cases were histo-
logically verified. 13 One of the reasons for a low biopsy
rate is obviously relative ease of access to pathology
laboratories, but also doctors are often reluctant to put
patients presenting with advanced cancer through addi-
tional painful diagnostic procedures. These results
therefore represent minimal cancer incidence rates for
the country.
The ASRs for 1988, ranging from 91,6/100 000 in
black males (LR 1/9,6) to 229,9 (LR 1/4,3) in white
males, and an average LR for the whole South African
population of at least 1/7 people, illustrate that cancer is
art important public health problem in this country.
Furthermore, 39,5% of cancers in females and 31,3% of
those in males occur in adult breadwinners aged IS - 54
years, with potential catastrophic consequences on
dependants.
Rates for cancers of the oesophagus, cervix and skin
rank among the highest in the world.2 Mesothelioma
tates, presented elsewhere,I,2 also rank among the
highest world-wide.
South African cancer patterns vary considerably from
those observed in developed countries, and from those
in other African countries. For example, cancer of the
SAMJ
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TABLE Ill.
Top 10 histologically diagnosed cancers, by sex and population group, 1988
Site No. % Crude* ASRt Risk:j: Site No. % Crude* ASRt Risk:j:
White females Coloured females
BCC 2293 22,69 87,43 67,34 14,11 Cervix 370 20,50 23,31 31,03 32,15
Breast 1834 18,15 69,93 58,76 15,96 Breast 317 17,56 19,97 29,13 30,62
SCC 772 7,64 29,44 19,97 43,06 Uterus 102 5,65 6,43 9,82 87,46
Colon 486 4,81 18,53 14,04 60,74 Stomach 97 5,37 6,11 9,15 100,50
Melanoma 387 3,83 14,76 12,06 82,47 Lung 84 4,65 5,29 7,99 97,59
Lung 307 3,04 11,71 10,10 81,15 Ovary 68 3,77 4,28 5,65 167,17
Uterus 319 3,16 12,16 10,05 81,15 Oesophagus 47 2,60 2,96 4,62 172,91
Non-Hodg. Colon 46 2,55 2,90 4,45 182,32
lymphoma 300 2,97 11,44 9,18 98,54 Non-Hodg.
Ovary 258 2,55 9,84 8,92 105,76 lymphoma 50 2,77 3,15 4,40 222,72
Cervix 268 2,65 10,22 8,86 108,03 Rectum 39 2,16 2,46 3,67 208,83
Other 2882 28,52 Other 585 32,41
-- --
Total§ 10106 100,00 287,5 201,3 5,0 Total§ 1805 100,00 109,9 148,1 6,6
White males Coloured males
BCC 3612 29,77 140,90 129,08 7,34 Lung 228 12,76 15,01 27,73 27,98
SCC 1366 11,26 53,29 48,15 18,59 Prostate 163 9,12 10,73 22,98 37,54
Prostate 863 7,11 33,66 27,12 32,15 Stomach 174 9,74 11,45 20,41 40,50
Bladder 736 6,07 28,71 25,82 31,85 Oesophagus 153 8,56 10,07 18,91 42,52
Lung 594 4,90 23,17 22,72 33,29 Larynx 90 5,04 5,92 11,19 78,63
Colon 431 . 3,55 16,81 15,11 58,30 Bladder 67 3,75 4,41 8,62 89,00
Leukaemia 354 2,92 13,81 13,40 81,80 Nas%ro/phx 63 3,55 4,15 7,41 133,83
Non-Hodg. Mouth 56 3,13 3,69 6,57 135,64
lymphoma 362 2,98 14,12 12,53 70,92 Tongue 51 2,85 3,36 5,8fj 154,35
Melanoma 333 2,74 12,99 11,71 82,47 BCC 41 2,29 2,70 5,44 167,17
Stomach 323 2,66 12,60 11,44 78,63 Other 701 39,23
Other 3160 26,04
--
-- Total§ 1787 100,00 112,8 192,2 5,0
Total§ 12134 100,00 279,2 229,9 4,3 Sex unknown 3
Sex unknown 389 Total coloureds 3 595--
Total whites 22629
Asian females
Black females Breast 104 23,27 22,53 26,45 37,96
Cervix 2783 32,74 21,12 39,28 21,25 Uterus 44 9,84 9,53 13,23 65,44
Breast 998 11,74 7,57 14,35 56,37 Cervix 44 9,84 9,53 11,49 76,26
Oesophagus 728 8,56 5,52 11,55 66,29 Colon 21 4;70 4,55 6,41 123,96
Uterus 370 4,35 2,81 5,87 125,50 Rectum 16 3,58 3,47 5,60 128,71
Liver 225 2,65 1,71 3,58 204,58 Stomach 17 3,80 3,68 5,56 196,58
Lung 215 2,53 1,63 3,49 222,72 Ovary 19 4,25 4,12 4,91 182,32
Ovary 220 2,59 1,67 3,09 263,66 Bladder 11 2,46 2,38 3,69 227,77
SCC 174 2,05 1,32 2,75 270,77 Mouth 11 2,46 2,38 3,39 227,77
Stomach 155 1,82 1,18 2,38 313,00 Leukaemia 14 3,13 3,03 2,91 625,50
Leukaemia 201 2,36 1,53 2,13 435,28 Other 146
Other 2432 28,61
--
-- Total§ 447 100,00 95,8 118,0 8,4
Total§ 8501 100,00 62,7 107,2 8,0 Asian males
Black males Lung 35 12,28 7,67 12,36 73,49
Oesophagus 1662 19,06 12,53 24,93 31,75 Bladder 28 9,83 6,14 9,71 75,69
Prostate 698 8,00 5,26 14,44 52,32 Stomach 24 8,42 5,26 9,56 72,44
Lung 959 11,00 7,23 13,96 56,68 Prostate 13 4,56 2,85 6,47 172,91
Liver 530 6,08 4,00 7,22 108,03 Non-Hodg.
Larynx 342 3,92 2,58 5,28 137,49 lymphoma 19 6,68 4,16 5,96 120,98
Mouth 303 3,47 2,29 4,82 147,56 Liver 15 5,26 3,29 5,41 141,35
SCC 271 3,11 2,04 4,09 217,89 Colon 12 4,21 2,63 5,06 127,08
Stomach 260 2,98 1,96 3,84 204,58 Rectum 12 4,21 2,63 4,86 208,83
Nas%ro/phx 246 2,82 1,86 3,78 200,50 Leukaemia 17 5,97 3,73 3,81 333,83
Tongue 220 2,52 1,66 3,44 213,27 Larynx 11 3,86 2,41 3,49 263,66
Other 3 231 37,04 Other 99-- --
Total§ 8722 100,00 63,2 112,2 7,5 Total§ 285 100,00 61,4 91,6 9,6
Sex unknown 212 Sex unknown 17--- --
Total blacks 17435 Total Asians 749
Females, pop. unknown 435
Males, pop. unknown 517
Pop. unknown, sex unknown 210
Total cancer cases 45570
" t: per 100 000.
:j:: lifetime risk, expressed as 1 in X number of people.
t, :j:: adjusted for age unknown.
§: total incidence rates and lifetime risks exclude BCC and SCC.
BCC ; basal cell carcinoma; SCC = squamous cell carcinoma.
South African population: Asian females - 461 533; Asian males - 456 187; black females - 13 179 019; black males - 13 258 992; coloured females - 1 587 225;
coloured males -1 519202; white females - 2622645; white males - 2563524; total 35 648 327.
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oesophagus is common in South Africa but virtually
absent in Mali (1,3/100 000 for males and 0,4 for
females") and in The Gambia « 11100000).10 Kaposi's
sarcoma, rare in South Africa (0,06% of all cancers in
females and 0,4% in males), comprises 48% of all can-
cers in males and 17% in females in Uganda (probably
because of the HIV epidemic). 14
Cancer of the cervix is the commonest cancer in
South African females (16,5% of cancers in all races,
but 32,7% in blacks) and in females from other African
countries, but ranges in relative importance from 13,4%
in Uganda to 51,5% in Swaziland. 15 Analysis of figures
from 27 current and past cancer registries in Africa (24
reported in Parkin, IS and the Gambian, Mali and South
African registries) shows that cancer of the cervix com-
prised less than 20% of all cancers in females in 6,
between 21 % and 30% in 11, and 30% in 10. Rates for
cancer of the cervix in South African black and coloured
women (ASR 39,28 and 31,03/100 000 respectively)
and in other African countries are among the highest in
the world. I In contrast, rates of cancer of the cervix
(1976 - 1980) in developed countries such as the
Nordic countries range from 6/100 000 in Finland to
19,4/1 00 000 in Denmark. ls National mass screening
programmes have been shown to be effective in reduc-
ing the incidence of this cancer. IS In the Nordic coun-
tries, for example, a 21 - 56% reduction in the incidence
of cancer of the cervix has been reported in Denmark,
Finland, Iceland and Sweden, countries with mass
screening programmes. In contrast Norway, which has
no organised mass screening service, experienced a 14%
increase in the incidence of cancer of the cervix between
the 1950s and 1980s.17 A national screening programme
for cancer of the cervix should be implemented to assist
in curbing this important epidemic.
Much is known about the effects of smoking on
cancer and other diseases in developed countriesY"
However, quantitative data are lacking in developing
(especially African) countries,!" and this relationship
ought to be investigated locally. Having said this, there
is no doubt that a reduction in cigarette consumption
would be an obvious step in reducing the incidence of
smoking-related cancers,' which in South Africa com-
prise 40,4% of cancers in adult males (15 - 64 years)
and 15,2% of those in adult females. Studies on the
lifestyle and dietary causes of cancer, especially cancers
associated with tobacco and cancers of the oesophagus,
cervix and skin, should be important priorities for
epidemiological research in South Africa. The impact of
HIV on the incidence of virus-related cancers is another
of the many areas in cancer research that deserves'
urgent attention.
Above all, permanent regional registries where cancer
is diagnosed irrespective of laboratory confirmation3
ought to be set up in a number of regions to provide
information on baseline incidence rates, geographical
distribution and trends. Such population-based cancer
registries are an important source of unambiguous infor-
mation on the burden of cancer and the effectiveness of
cancer control programmes.
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